You are here

NIH

Why Shares of Cassava Sciences Rose 15% Today

Motley Fool

Thu, 09/23/21 - 10:48 pm

Cassava Sciences

Alzheimer's disease

NIH launches study into COVID-19 vaccine booster among people with autoimmune disease

Biopharma Reporter

Wed, 09/1/21 - 11:04 am

autoimmune disease

clinical trials

Large clinical trial to study repurposed drugs to treat COVID-19 symptoms

NIH

Wed, 04/21/21 - 10:31 am

clinical trials

drug repurposing

Regeneron’s Covid mAb as a prophylactic injection: Reduced risk of symptomatic infection by 81%

Endpoints

Mon, 04/12/21 - 11:09 am

monoclonal antibodies

U.S. begins study on allergic reaction risk in Moderna, Pfizer vaccines

Yahoo/Reuters

Wed, 04/7/21 - 10:28 am

Moderna Therapeutics

allergic reactions

clinical trials

Regeneron shoots for longer Eylea dosing interval in diabetic retinopathy with NIH data

Fierce Pharma

Fri, 04/2/21 - 10:55 am

diabetic retinopathy

Is a 'super-seasonal' flu vaccine on the horizon? The NIH and UW are taking a shot into the clinic this April

Endpoints

Thu, 03/25/21 - 11:20 am

universal flu vaccine

University of Washington

AstraZeneca’s Covid-19 vaccine data may have ‘outdated information,’ NIH cautions

MedCity News

Tue, 03/23/21 - 10:46 am

Brii Bio joins the NIH graveyard alongside GSK, Lilly after flopping antibody study in hospitalized Covid-19 patients

Endpoints

Fri, 03/5/21 - 10:47 am

Brii Biosciences

AI-designed serotonin tracker could help develop neurology drugs

Pharmaforum

Sat, 12/26/20 - 08:19 pm

artificial intelligence

NIH Is Planning A Study To Find Out What’s Causing Allergic Reactions To Pfizer’s Covid-19 Vaccine

Forbes

Mon, 12/21/20 - 11:36 pm

allergic reaction

GlaxoSmithKline, Vir look to succeed where Lilly failed with NIH antibody study in hospitalized Covid-19 patients

Endpoints

Thu, 12/17/20 - 06:25 pm

Vir Biotechnology

clinical trials

Study: ECMO ‘significantly’ improves heart attack patients’ survival

Mass Device

Mon, 11/16/20 - 10:15 am

Coronavirus vaccine trial leader Larry Corey on the tough FDA, policy decisions to come

BioPharma Dive

Tue, 10/20/20 - 10:55 am

Moderna Therapeutics

Eli Lilly and Gilead’s combination cuts COVID-19 recovery time

Pharmaforum

Fri, 10/9/20 - 10:52 am

Gilead Sciences

clinical trials

AstraZeneca's COVID-19 vaccine adverse event has NIH 'very concerned'

Fierce Biotech

Wed, 09/16/20 - 10:57 am

clinical trials

NIH advisors say data doesn't support plasma use for COVID-19

BioPharma Dive

Wed, 09/2/20 - 11:00 am

convalescent plasma

Alzheon returns, with a $47 million NIH grant and one last shot at a pivotal PhIII Alzheimer’s success

Endpoints

Thu, 08/20/20 - 10:43 am

Alzheimer's disease

Gilead's COVID med remdesivir is scarce and costly, AGs say, urging feds to sidestep its patents

Fierce Pharma

Wed, 08/5/20 - 11:14 pm

Gilead Sciences

Seven plucky diagnostics companies win a $249M round of contracts after surviving NIH's Covid-19 'Shark Tank' competition

Endpoints

Mon, 08/3/20 - 11:37 pm

Talis Biomedical

Ginkgo Bioworks

Mammoth Biosciences

Pages